Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Molecular Medicine, |
RCV001030045 | SCV001190567 | pathogenic | Peroxisome biogenesis disorder 1A (Zellweger) | 2019-05-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003473610 | SCV004203396 | pathogenic | Heimler syndrome 1 | 2021-12-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003594089 | SCV004294508 | pathogenic | Zellweger spectrum disorders | 2023-05-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg577Thrfs*15) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 9398847, 16086329, 16141001, 21031596, 26387595, 31831025). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Zellweger syndrome (PMID: 28432012). ClinVar contains an entry for this variant (Variation ID: 830063). For these reasons, this variant has been classified as Pathogenic. |